A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and ...

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

Apitegromab, a fully human monoclonal antibody, works by selectively binding to the pro- and latent forms of myostatin in order to inhibit myostatin activation.

Conversations with over a dozen college students across the US revealed fears of developing an over-reliance on AI.

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...

A new study found that highly educated people may suffer steeper cognitive decline after a stroke compared to those with less ...

When someone has a stroke, it can accelerate the loss of cognitive ability over the coming years. Stroke survivors who have ...

Stroke survivors who have some level of higher education could face more profound cognitive decline due to a stroke, ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The tiger arrived to the zoo in 2008 after being rescued from a wildlife trafficking operation, the zoo said. It lived to age ...